Portola Pharmaceuticals to Participate in Two Upcoming Investor Conferences

On August 30, 2018 Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) reported that the company will participate in the following conferences in September (Press release, Portola Pharmaceuticals, AUG 30, 2018, View Source;p=RssLanding&cat=news&id=2365495 [SID1234529231]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 13th Annual Biotech Conference on Thursday, September 6, 2018 in Boston, MA. The Company will conduct one-on-one meetings with institutional investors at this conference.

Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday, September 12, 2018, at 2:15 p.m. Eastern Time in New York, NY. The Company will participate in a fireside chat presentation at the conference, which will be webcast live and available for replay from Portola’s website at www.portola.com in the Investor Relations section.